Executive Directors

• Dr. Wang Hao - Executive Director, Chief Executive Officer and Chief Scientist

  Dr. Wang Hao ("Dr. Wang") was appointed as an Executive Director and Chief Scientist of the Company in July 2018, and was appointed as the Chief Executive Officer of the Company in October 2020. He is primarily responsible for overseeing the operation and management of our Group and has over 24 years of experience in the medical and pharmaceutical technology industry.

  Dr. Wang obtained a Ph.D. in medicine in June 1997 from the Second Military Medical University (currently known as the People's Liberation Army Navy Medical University).

  Dr. Wang was awarded twice with the National Award for Science and Technology Progress in December 2011 and December 2007, respectively, the Shanghai Oriental Scholar Professorship in June 2008, and the Shanghai Award for Science and Technology Progress in December 2003.

• Mr. Li Yunfeng - Executive Director, Vice President and Joint Company Secretary

  Mr. Li Yunfeng ("Mr. Li") was appointed as an Executive Director of the Company in July 2018, and has served as the Joint Company Secretary since May 2019. Mr. Li was appointed as the Vice President of the Company in July 2024. He is primarily responsible for overseeing the Group's management of business development, investment and legal work. Mr. Li has over 20 years of experience in the biotechnology industry.

• Mr. Tao Jing - Executive Director and Vice President

  Mr. Tao Jing ("Mr. Tao") joined the Group in February 2015 and was appointed as the vice president of the Company and general manager of Taizhou Mabtech Pharmaceutical Co., Ltd., an indirect wholly-owned subsidiary of the company, in August 2018. Mr. Tao was appointed as the executive director of the Company in Octorber 2020 and was elected as a member of the sixth session of the Standing Committee of Taizhou Gaogang District People's Congress in January 2022. He is primarily responsible for overseeing production of drugs of the Group. Mr. Tao also obtained an advanced certificate in biochemistry from Shanghai Municipal Human Resources and Social Security Bureau in November 2013.

• Dr. Hou Sheng - Executive Director and Vice President

  Dr. Hou Sheng ("Dr. Hou") was appointed as an executive director of the Company in November 2023, and was appointed as a vice president of the Company in December 2023. He is mainly responsible for overseeing the Group's medical, drug registration and clinical studies. Dr. Hou has over 20 years of experience in oncology and biology fields. Dr. Hou received a Ph.D. in medicine from the Second Military Medical University (currently known as People's Liberation Army Navy Medical University) in June 2005.

  Dr. Hou received second prize in State Technological Invention Award in 2007, first prize in Shanghai Science and Technology Award two times in 2006 and 2011 respectively, and second prize in Shanghai Technology Invention Award.

• Dr. Qian Weizhu - Executive Director and Vice President

  Dr. Qian Weizhu ("Dr. Qian") joined the Group in February 2015 and served as an executive director and Chief Executive Officer of the Company from August 2018 to October 2020. Dr. Qian was appointed as a non-executive director of the Company in November 2023 and was re-designated as an executive director and vice president of the Company in July 2024. Dr. Qian has more than 25 years of experience in oncology and biology fields and was awarded a doctorate degree in oncology from Second Military Medical University (currently known as People's Liberation Army Navy Medical University) in June 2011.

Non-executive Directors

• Mr. Jiao Shuge - Chairman and non-executive Director

  Mr. Jiao Shuge (“Mr. Jiao”) was appointed as the chairman and a Non-Executive Director of the Company in July 2018. He is responsible for participating in formulating the Group's business and corporate strategies.

• Mr. Cen Jialin - Non-executive Director

  Mr.Cen Jialin (“Mr. Cen”) was appointed as a Non-Executive Director of the Company in July, 2024. He is responsible for participating in formulating the Group's business and corporate strategies.

Independent non-executive Director

• Mr. Guo Liangzhong - Independent non-executive Director

  Mr. Guo Liangzhong (“Mr. Guo”) is an Independent Non-Executive Director of the Company and was appointed as a Director in August, 2018, effective from May 31, 2019. Mr. Guo worked as an officer in the accusation department at the Supreme People's Procuratorate of the People's Republic from March 1991 to July 1993.

• Dr. Zhang Yanyun - Independent non-executive Director

  Dr. Zhang Yanyun (“Dr. Zhang”) is an Independent Non-Executive Director of the Company and was appointed as a Director in August, 2018, effective from May 31, 2019. Dr. Zhang has been a non-resident research fellow and principal investigator at Shanghai Institute for Biological Sciences, Chinese Academy of Sciences(Currently known as Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences） since 2017.

• Mr. Leung, Louis Ho Ming - Independent non-executive Director

  Mr. Leung, Louis Ho Ming (“Mr. Leung") is an Independent Non-Executive Director of the Company and was appointed as a Director in June, 2022. Mr. Leung holds abachelor degree of Science in Quantitative Finance from The Chinese University of Hong Kong in 2004. He has been a member of Hong Kong Institute of Certified Public Accountant since 2008 and has over 10 years of experience in accounting and auditing for Hong Kong listed and private companies.

• Dr. Tao Qian - Independent non-executive Director

  Dr. Tao Qian (“Dr. Tao”) is an Independent Non-Executive Director of the Company and was appointed as a Director in July, 2024. Dr. Tao currently serves as a professor of department of clinical oncology at The Chinese University of Hong Kong and is a leader in cancer epigenetics and tumor suppressor genes study in Asia.